1月6日，博苑股份涨5.04%，截至发稿，报87.39元/股，成交5689.56万元，换手率1.25%，总市值116.79 亿元。 从博苑股份十大流通股东角度 数据显示，鹏华基金旗下1只基金位居博苑股份十大流通股东。鹏华汇智优选混合A（010894）三季度 新进十大流通股东，持有股数43.42万股，占流通股的比例为1.3%。根据测算，今日浮盈赚取约181.95 万元。 资料显示，山东博苑医药化学股份有限公司位于山东省寿光市侯镇海洋化工园区新海路与大九路路口北 200米，成立日期2008年8月6日，上市日期2024年12月11日，公司主营业务涉及专业从事精细化学品研 发、生产、销售及资源综合利用的高新技术企业,主营业务包括有机碘化物、无机碘化物、贵金属催化 剂、发光材料、六甲基二硅氮烷等产品的研发、生产、销售,并基于资源综合利用资质与工艺技术优势 开展含碘、贵金属等物料的回收利用业务,为客户提供贵金属催化剂、六甲基二硅氮烷等加工服务。主 营业务收入构成为：碘化物74.56%，特种功能化学品12.79%，贸易业务9.94%，其他2.72%。 鹏华汇智优选混合A（010894）成立日期2021年1月8日，最新规模3 ...

Group 1 - The core business of Shandong Boyuan Pharmaceutical Chemical Co., Ltd. includes the research, production, and sales of fine chemicals, with a focus on organic iodides (74.56% of revenue), specialty functional chemicals (12.79%), trading (9.94%), and others (2.72%) [2] - As of December 10, 2025, the company reported a revenue of 1.073 billion yuan, representing a year-on-year growth of 6.60%, while the net profit attributable to shareholders decreased by 22.53% to 132 million yuan [2] - The company has distributed a total of 88.408 million yuan in dividends since its A-share listing [3] Group 2 - On December 19, 2025, Boyuan shares increased by 0.53%, with a trading volume of 93.8648 million yuan, and a net financing purchase of 448,700 yuan [1] - The total margin trading balance for Boyuan shares reached 142 million yuan, accounting for 3.68% of the circulating market value, which is above the 70th percentile of the past year [1] - As of December 19, 2025, there were no shares sold or repaid in the securities lending market, indicating a high level of demand for borrowing [1]

证券日报网讯12月11日，新亚强（603155）在互动平台回答投资者提问时表示，公司六甲基二硅氮烷产 品是锂电池电解液的关键功能性助剂，目前已与国内多家头部电解液生产企业建立了长期、稳定合作关 系。公司相关产能充足，能够有效满足市场需求。湖北新亚强承建的有机硅材料及高纯功能助剂产品项 目，目前尚在推进中。 ...

格隆汇12月11日丨新亚强(603155.SH)在投资者互动平台表示，公司六甲基二硅氮烷产品是锂电池电解 液的关键功能性助剂，目前已与国内多家头部电解液生产企业建立了长期、稳定合作关系。公司相关产 能充足，能够有效满足市场需求。湖北新亚强承建的有机硅材料及高纯功能助剂产品项目，目前尚在推 进中。 ...

投资者关系活 动类别 ☑ 特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他（请文字说明其他活动内容） 参与单位名称 及人员姓名 中银证券、长盛基金、天弘基金 时间 2025 年 12 月 9 日 地点 博苑股份会议室 上市公司接待 人员姓名 1、董事长：李成林 2、证券事务代表：杨艳丽 投资者关系活 动主要内容介 绍 1、公司精细化学品产品种类有哪些？ 答：公司精细化学品主要包括碘化物、发光材料、六甲基 二硅氮烷和贵金属催化剂等品类，其中碘化物产品收入占比居 各品类首位，为核心营收贡献品类。 2、贵公司碘化物产品产能及相关品类？ 答：公司碘化物产品现有产能 4,100 吨/年，试生产阶段项 目 4,000 吨/年。其中，无机碘化物主要包括碘化钾、碘酸钾、 碘化钠、氢碘酸、碘化亚铜等；有机碘化物产品主要有三甲基 碘硅烷、碘甲烷等。 3、公司 4000 吨/年无机碘化物生产项目的建设进度？ 答：公司 4000 吨/年无机碘化物生产项目，已于 2025 年 12 月 5 日正式进入试生产阶段。 4、公司无机碘化物产品的市场前景？ 答：从下游主要需求领域角度看，无机碘 ...

Core Viewpoint - The actual controller of Xinyaqiang (603155.SH), a leader in the silicone industry, has changed to the Handan State-owned Assets Supervision and Administration Commission following a share transfer agreement with the Handan City Chengxin Equity Investment Fund for 1.96 billion yuan [3][6]. Shareholder Changes - On November 25, Xinyaqiang announced that the Handan Chengxin Equity Investment Fund acquired 94.42 million shares from the previous major shareholder, Chu Lin, for 20.76 yuan per share, representing a premium of approximately 15.2% over the closing price on the announcement date [3][5][8]. - After the transfer, the Chengxin Fund will hold 29.9% of Xinyaqiang's total shares, making it the largest shareholder, while Chu Lin's stake will decrease to 16.09% [5][6]. Company Background - Xinyaqiang, established in 1992 and listed on the Shanghai Stock Exchange in September 2020, specializes in silicone functional additives and phenyl chlorosilane, with its products integrated into the semiconductor and new energy supply chains [7][8]. - The company's core product, hexamethyldisilazane, is recognized as a key material in chip photolithography processes [7]. Industry Context - The change in control comes amid a supply-demand adjustment in the silicone industry, with companies planning a 30% production cut starting in December [8][9]. - Xinyaqiang's performance has been declining, with a significant drop in revenue and net profit since 2022 due to rapid capacity expansion in the industry [8][9][12]. Financial Performance - Xinyaqiang's revenue and net profit have fluctuated significantly over the past few years, with a peak in 2021 followed by a decline in subsequent years. For instance, the net profit for 2024 is projected at 114 million yuan, down over 60% from the 2021 peak [9][12]. - The company's gross margin has also decreased from 43.15% in 2021 to 20.77% in 2024 [9]. Management Transition - The transition of control is linked to challenges in management succession and declining performance. Initial leadership changes occurred in 2023, but the transition has not been smooth [13][14]. - The Handan Chengxin Fund has committed to maintaining control for at least 18 months and will not transfer control for seven years after acquiring it [16].

邯郸国资为此次交易开出了每股20.76元的转让单价，相比公告前一日16.48元的收盘价，溢价高达26%。 交易完成后，初亚军家族的持股比例从47.51%降至 17.61%，虽然不再是实际控制人，但仍是公司第二大股东。 这笔交易的付款安排异常高效。 根据协议，签署后1个工作日内支付1.9亿元定金，协议生效后15个工作日内支付3.8亿元，取得交易所合规性确认后5个工作 日内支付12亿元，股份过户完成后3个工作日内支付剩余尾款。 这种安排确保了初亚军家族能够迅速获得大部分转让款项。 为保障公司稳定过渡，交易双方都做出了重要承诺。 城欣基金承诺取得控制权后7年内不转让控制权，18个月内不转让所持股份；初亚军家族方面则承诺不 谋求公司控制权。 新亚强并非一家普通化工企业，而是在有机硅精细化学品领域具有全球竞争力的"隐形冠军"。 公司核心产品"六甲基二硅氮烷"作为光刻胶助粘剂，成功打 破了日本化学巨头在该领域的垄断。 在技术方面，新亚强自主研发的"无溶剂法"专利技术实现了突破，使其生产的电子级六甲基二硅氮烷纯度高达99.95%，远超行业标准。 这一技术突破不仅 填补了国内空白，更使新亚强成为全球少数能稳定供应半导体级六甲 ...

Core Viewpoint - The acquisition of controlling stake by Handan Municipal Government's State-owned Assets Supervision and Administration Commission (SASAC) in Xinyaqiang (603155.SH) signifies a strong recognition of the company's solid fundamentals and high-quality asset value, potentially serving as a model for state capital's strategic investment in high-end manufacturing and industrial upgrading [1] Group 1: Company Overview - Xinyaqiang has focused on the research and production of silicone functional additives and specialty monomers since its establishment in 1992, becoming the first domestic producer to break foreign monopolies in hexamethyldisilazane [2] - The company's product matrix includes high-value areas such as methyl, vinyl, and phenyl, with overseas market revenue accounting for 38.23%, establishing a stable profit base [2] - Xinyaqiang's electronic-grade materials are deeply integrated into the semiconductor, flat panel display, and new energy supply chains, making it a key player in the domestic substitution process [2] Group 2: Financial Health - As of the end of Q3 2025, Xinyaqiang reported total assets of 2.387 billion, with total liabilities of only 185 million, resulting in a low asset-liability ratio of 7.75%, significantly below the chemical industry average [3] - The company holds 1.597 billion in cash and trading financial assets, indicating a strong cash position that reduces operational risks and enhances strategic execution [3] - In 2024, Xinyaqiang achieved a net profit attributable to shareholders of 114 million, with basic earnings per share of 0.36, and a net operating cash flow of 169 million, reflecting a solid operational foundation [3] - The company maintains a high dividend tradition, with a payout ratio of 193% in 2024 and cumulative cash dividends of 446.6 million over the past three years, demonstrating a strong commitment to shareholder returns [3] Group 3: Strategic Collaboration - The entry of Handan SASAC is based on a deep recognition of Xinyaqiang's core value and long-term strategic expectations, with a commitment to not transfer control for seven years [4] - Handan SASAC aims to leverage its industrial resources to promote the company's growth in high-end fields such as semiconductor materials and new energy additives through industry chain integration, new business development, and financing channel optimization [4]

Core Viewpoint - The article discusses the proposed transfer of control of Xinyaqiang, a leading organic silicon additive company, to Handan State-owned Assets Supervision and Administration Commission, following a share transfer agreement signed by the current controlling shareholder, Chu Lin [2][8]. Group 1: Share Transfer Details - On November 24, Chu Lin signed a share transfer agreement to sell 94.42 million shares at a price of 20.76 CNY per share, totaling approximately 1.96 billion CNY [8][7]. - After the transfer, the new controlling shareholder, Chengxin Fund, will hold 29.90% of Xinyaqiang's shares, while Chu Lin will retain 16.09% [9][8]. - The share transfer represents a premium of about 26.7% compared to the closing price of 16.38 CNY per share on November 24 [8][7]. Group 2: Company Performance and Financials - Xinyaqiang has experienced significant revenue fluctuations, with a reported revenue of 451 million CNY for the first three quarters of 2025, a year-on-year decrease of 19.05% [17]. - The net profit attributable to shareholders for the same period was approximately 78.85 million CNY, down 20.39% year-on-year, primarily due to declining product margins [17]. - Despite the performance volatility, Xinyaqiang maintains a strong cash position and has a high dividend payout ratio, with a total dividend payment rate of 193% in 2024 [17][10]. Group 3: Strategic Intentions - The share transfer aims to optimize the shareholder structure and enhance the company's credit level and risk resistance, while also expanding brand influence and new business development capabilities [10][12]. - Chengxin Fund has committed not to transfer control for seven years after acquiring it [12]. - Xinyaqiang is actively exploring sustainable investment opportunities in advanced materials, semiconductors, and high-end equipment sectors [17].

Core Viewpoint - On November 17, 2023, Boyuan Co., Ltd. experienced a decline of 3.80% in stock price, with a trading volume of 299 million yuan, indicating potential market concerns regarding the company's performance and investor sentiment [1]. Financing Summary - On the same day, Boyuan Co., Ltd. had a financing buy-in amount of 25.66 million yuan and a financing repayment of 35.66 million yuan, resulting in a net financing outflow of 9.99 million yuan [1]. - As of November 17, the total financing and securities lending balance for Boyuan Co., Ltd. was 169 million yuan, which represents 5.56% of its circulating market value [1]. - There were no shares sold or repaid in the securities lending segment on November 17, with a remaining balance of 0 yuan [1]. Company Overview - Boyuan Co., Ltd., established on August 6, 2008, is located in Shouguang City, Shandong Province, and specializes in the research, production, and sales of fine chemicals, including organic and inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane [2]. - The company's revenue composition includes iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [2]. - For the period from January to September 2025, Boyuan Co., Ltd. reported a revenue of 1.073 billion yuan, reflecting a year-on-year growth of 6.60%, while the net profit attributable to shareholders decreased by 22.53% to 132 million yuan [2]. Shareholder Information - As of November 10, 2025, Boyuan Co., Ltd. had 11,900 shareholders, a decrease of 12.88% from the previous period, with an average of 2,813 circulating shares per shareholder, an increase of 14.78% [2]. - The company has distributed a total of 88.41 million yuan in dividends since its A-share listing [3]. - Notable new institutional shareholders include Zhonghang New Start Flexible Allocation Mixed A, holding 1.3456 million shares, and several other funds that have recently entered the shareholder list [3].